Search results
Results from the WOW.Com Content Network
The fixed-dose combination of pertuzumab, trastuzumab, and hyaluronidase was approved for medical use in the United States in June 2020. [5] [10]The FDA's approval was based on the results of a non-inferiority study in participants with HER2-positive early breast cancer, which demonstrated the fixed-dose combination of pertuzumab, trastuzumab, and hyaluronidase had comparable efficacy and ...
Pertuzumab is administered as an intravenous infusion in combination with trastuzumab and docetaxel as a first line treatment for HER2-positive metastatic breast cancer. [4] [3] It is also used in the same combination as a neoadjuvant (given to reduce the size of a tumor, prior to surgery or radiation) for HER2-positive early breast cancer; as of 2016 this use had not been shown to increase ...
Another option is Diberri and Boghog's excellent Wikipedia template filling tool which will generate a populated template to copy and paste into an article if "DrugBank ID" is selected in the dropdown menu and a DrugBank ID number (which may be obtained from DrugBank search) is added in the adjacent field.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Donate
This is the template test cases page for the sandbox of Template:Infobox drug to update the examples. If there are many examples of a complicated template, later ones may break due to limits in MediaWiki; see the HTML comment "NewPP limit report" in the rendered page. You can also use Special:ExpandTemplates to examine the results of template uses. You can test how this page looks in the ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
data page Cocaine <=> Cocaine (data page). data page will link to [[pagename]] for data page (dflt: link to "Articlename (data page)"); Not a parameter. EC_number (it ...
This template is used on approximately 14,000 pages and changes may be widely noticed. Test changes in the template's /sandbox or /testcases subpages, or in your own user subpage . Consider discussing changes on the talk page before implementing them.